Johnson & Johnson Consumer, Inc. manufactures health and skin care products. It offers wide variety of lotion, moisturizing cream, baby wash, shampoo and conditioner, baby powder and bath, hand and face wipes, soap, baby oil and cologne. The company was founded on March 8, 2016 and is headquartered in Skillman, NJ.

Otsuka Holdings operates in pharmaceuticals, nutraceuticals, and consumer products. The business activity of the company includes providing healthcare solutions in the areas of the nervous system, oncology, cardiovascular system, respiratory system, infectious disease, and others. The company engages in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks, and dietary foods.

Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA.

Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.

Hadasit is the technology transfer company of Hadassah Medical Center in Jerusalem. They transform the cutting-edge research coming out of Hadassah into marketable medical technologies. They turn ground-breaking ideas into viable products and services that can change the world and better humanity. For more than a century, Hadassah has set the standard of excellence for medical care and research in Israel. Their doctors and scientists are on the frontlines, uniquely positioned to pinpoint ever-evolving medical needs. Their experience and ingenuity has yielded new ideas with huge potential in all areas of medicine, including therapeutics, diagnostic medical devices, and digital health. More than half of all hospital research in Israel is conducted at Hadassah. Hadasit is Hadassah’s vehicle for commercialization of the intellectual property and R&D capabilities developed there. Hadasit holds exclusive rights to every innovation and invention emerging from Hadassah and they are dedicated to bringing these life-saving technologies to the general public.

Part of GSK Plc, Beecham Group Plc is a British company located in Middlesex. The firm functions as an investment holding company. It was founded in 1928.\nThe company says this about itself: The principal activity Of the Company is the holding of Intercompany bans and receipt Of interest. The Company had previously been an investment holding company. The Company is a member Of the GlaxoSmithKline Group (the 'Group\"). The directors do not envisage any change to the nature of the business in the future,

Manufactures pharmaceuticals

Beiersdorf AG is engaged in the development, manufacture, and distribution of skin and personal care products. The firm operates through the Consumer and Tesa segments. The Consumer segment concentrates on the international skin and body care markets. The Tesa segment manufactures self-adhesive products and solutions for industry, craft businesses, and consumers. It offers its products and system solutions to industry, craft businesses, and consumers. Its brands include Eucerin, La Prairie, Labello, and Hansaplast. The company was founded by Paul C. Beiesdorf in 1882 and is headquartered in Hamburg, Germany.

ZZ Biotech LLC is a clinical stage company developing innovative biologic treatments for ischemic stroke. ZZ Biotech was formed in 2006 to focus on the development of 3K3A-APC, a novel second-generation variant of a naturally occurring human protein, activated Protein C (APC). The major unwanted side effect of APC is bleeding, which limits its pharmacologic dosing in man. 3K3A-APC has markedly reduced anticoagulant activity, but preserved cell-protective and anti-inflammatory activities compared to wild-type APC. In animal models of stroke 3K3A-APC has shown an advantage over wild-type APC in enhanced efficacy and reduced risk for bleeding. Additionally, the combination of 3K3A-APC and tissue Plasminogen Activator (tPA) provides benefits well beyond those found with either agent alone. ZZ Biotech is currently recruiting patients in a multicenter Phase 2 clinical trial of 3K3A-APC in patients suffering from acute ischemic stroke. The study is being supported by the National Institutes of Health through a pair of NeuroNEXT grants. The Phase 2 study is to evaluate safety, tolerability and activity of ZZ Biotech’s 3K3A-APC when given after tissue plasminogen activator (tPA), mechanical thrombectomy, or both, in patients who have experienced moderate to severe ischemic stroke.

Tianyi Intelligent Technology (Dongguan) Co., Ltd., established on 2019-08-23, Business scope includes general items:Artificial intelligence industry application system integration service;Manufacturing of lighting fixtures;Lighting Sales;Lighting sales;Manufacturing of Semiconductor Lighting Devices;Sales of Semiconductor Lighting Devices;integrated circuit manufacturing;IC sales;IC Design;Production of battery spare parts;Battery spare parts sales;battery sales;Manufacturing of photovoltaic equipment and components;Photovoltaic equipment and components sales;Manufacturing of electronic components;Electronic Components Retail;electronics sales;Video recording and playback equipment manufacturing;Household Appliance Manufacturing;Research and Development of Household Appliances;Home Appliance Sales;Smart home consumer device sales;Manufacturing of Smart Home Consumer Devices;Import and export;Technology Import and Export;Energy Storage Technology Services;software development.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Dong-A Pharmaceutical Co., Ltd., a subsidiary of Dong-A Socio Holdings Co., Ltd., is a company headquartered in Seoul, the South Korea, that manufactures drug products.

miro - Verbandstoffe GmbH is a private company headquartered in Germany that distributes medical, orthopedic, dental and laboratory equipment.

Guangzhou Baoshengtang Pharmaceutical Biotechnology Co., Ltd., established on 2001-01-15, Business scope includes food business(Only sell prepackaged food);Domestic trade agent;marketing planning;Corporate Image Planning;Consulting and planning service;Information Consulting Service(Not including licensing information consulting services);Business Management Consulting;Sales of Class II Medical Devices;Sales of Class I Medical Devices;Health Care Services(non-medical);Traditional Chinese Medicine Health Care Services(non-medical);Health Consulting Services(Does not include medical services);Maternal and baby products sales;daily mask(non-medical)Sales;Wholesale medical masks;internet sales(Except for products that require a license for sale);Chemical product sales(No licensed chemical products);Sales of daily chemical products;Disinfectant sales(Free of Hazardous Chemicals);Personal Hygiene Sales;Sales of hygiene products and single-use medical products;Sales of packaging materials and products;Information Technology Consulting Services;R&D and application of cell technology;Human stem cell technology development and application;New material technology promotion service;Biochemical product technology research and development;Biomass Energy Technology Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Cosmetics Retail;Cosmetics Wholesale;Daily necessities sales;Daily necessities wholesale;Manufacturing of daily chemical products;Disinfectant production(Free of Hazardous Chemicals);food production;Medical beauty service;beauty service;Food Internet Sales(Selling prepackaged food);Health food sales;food business;Import and export;Disinfection equipment sales;Technology Import and Export;Cosmetic production;

L & C Bio Co., Ltd. is making the health and happiness of mankind based on their mission to improve the quality of human life and to give better value to their customers. And the efforts of L & C Bio Co., Ltd. start with the business philosophy of 'respecting customers', 'grasping needs' and 'providing the best products and services

Henan Provincial Peoples Hospital is a Chinese private company located in Zhengzhou. The firm operates as an hospital.

Lanhai (Fujian) Biotechnology Co., Ltd., established on 2017-09-17, The scope of business includes the research and development of plant active ingredients,extract,separate,synthesis;Biotechnology Consulting,Technical Services,technology transfer;cosmetic(Skin care),shampoo and conditioner,Production of cleansing cosmetics,processing,Sales;daily necessities,crafts,Production of agricultural by-products,processing,Sales;Rough processing of tea,Sales;Chinese herbal medicine,flower planting.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Medisan is a Moldovan private company, with operations in UA, that owns and operates spa.

Photocure ASA engages in the development and commercialization of pharmaceutical products based on photodynamic technology. Its products include Metvix for nonmelanoma skin cancer, Hexvix/Cysview for better detection and management of bladder cancer, and Cevira which is a photodynamic drug-device combination product for non-surgical treatment of high-grade cervical dysplasia. The company operates through the Commercial Franchise and Development Portfolio segments. The Commercial Franchise segment includes the sale of Hexvix/Cysview in the U.S. and Europe and other sales from partners and other products. The Development Portfolio segment focuses on the development of pipeline products. The company was founded in 1997 and is headquartered in Oslo, Norway.

Ligand is a biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines. Ligand business model creates value for stockholders by providing a diversified portfolio of biotech and pharmaceutical product revenue streams that are supported by an efficient and low corporate cost structure. Ligand's goal is to offer investors an opportunity to participate in the promise of the biotech industry in a profitable, diversified, and lower-risk business than a typical biotech company. Ligand business model is based on doing what we do best: drug discovery, early-stage drug development, product reformulation, and partnering. Ligand partner with other pharmaceutical companies to leverage what they do best (late-stage development, regulatory management, and commercialization) to ultimately generate Ligand revenue.